4 stocks primed for over 15% growth in earnings

Here are four companies that despite the weak state of the economy are expected to boost EPS at a lightening pace.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One concern a number of market participants presently have is that much of the rally in share prices over the past year would appear to be a result of an expansion of price-to-earnings (PE) multiples rather than because of growth in earnings per share (EPS). This has led a number of commentators to suggest that investors need to be careful and not get carried away — if earnings growth does not eventuate, then many stocks may appear very expensive and have serious downside risk.

With that in mind, identifying stocks that have a high likelihood of meeting consensus forecasts and that should post strong earnings growth to justify their current multiples is as important as ever. Here are four stocks that, according to Morningstar's research, are forecast to grow their EPS by over 15% this current financial year.

1. CSR (ASX: CSR) is a well-known building supplies company that reported earnings of 6.6 cents per share (cps) at its most recent full-year results. CSR is forecast to earn 11.8 cps in FY 2014, which implies a 78.8% increase.

2. IRESS (ASX: IRE) provides critical software to the financial services sector in Australia as well as a host of other countries. IRESS is forecast to grow EPS from 29.6 cps to 34.2 cps, implying growth in EPS of 15.5%.

3. REA Group (ASX: REA) is better known by its flagship website realestate.com.au. The company continues to expand both in Australia and abroad and is forecast to grow EPS from 83.3 cps to 105 cps. If it meets this forecast it will have grown EPS over the year by 26%.

4. Goodman Fielder (ASX: GFF) owns many of Australia's best known food brands including Meadow Lea and White Wings. The firm has had a difficult few years, however the future is looking brighter with expectations that EPS will increase this year from 3.7 cps to 5.2 cps, implying a growth rate of 40.5%.

Foolish takeaway

While Goodman Fielder and CSR are coming off of a depressed earnings base, REA and IRESS continue to produce solid results year after year. The problem for investors is being alert to the opportunities to purchase companies such as these when the price on offer compared to the value is in their favour.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »